Marin Biologic Laboratories
  • 415-883-8000
  • home
  • Services
      • cGMP/GLP
      • Cell Based Assays
      • ELISA
      • Flow Cytometry
      • Protein
      • Stability Services
      • Immunoassays
      • MLR
      • PCR-qPCR
      • Exosomes
      • Lot Release Potency Assay/Test
      • Transfection
      • RadioImmunoassays
      • The Art and Science of Cell Culture
      • Molecular Biology and Microbiology

  • Targeted Service Products
      • Gene Therapy
      • Antiviral Therapy
      • Immunotherapy
      • IDEA-to-IND
  • Assay Requirements
      • Assay Requirements
      • cGMP/FDA
      • GLP-GMP
      • NON-GLP/GMP
      • Litigation

  • company
      • About Us
      • Our Clients
      • Our Executive Team
      • FAQ
      • Glossary
      • Our Blog
      • Careers
      • Contact Us

  • science center

Blog

  • Sr. Scientist

    Posted on Jul 12, 2018

    This is exactly the kind of conversation that keeps me coming back to your Company

    Contact Us
    read more
    • share this

Recent Posts

  • Photorealistic image showing ADC molecules binding to a cancer cell, illustrating the precision of cell-based assays in cancer treatment
    Revolutionizing Cancer Treatment: How Potency Assays Make ADCs More Effective
  • Potency Assay for Bispecific Antibody Constructs
  • Novel High Sensitivity Bispecific Antibody ELISA
  • Implementing cGMP Potency Assays in PROTAC Drug Development
  • Illustration of the ubiquitin-proteasome system tagging and degrading a protein, a process similar to PROTAC drug action
    Expanding the Toolbox of PROTAC Degraders with Covalent Ligands for Genetically Validated Targets
  • Expanding the Eligibility for AAV Gene Therapy with Monoclonal Antibodies
  • Capsid engineering of adeno-associated virus (AAV) vectors

Categories

  • All Blogs
  • Assay Development
  • Biochemistry
  • Cell Biology
  • Client Projects
  • Covid-19
  • ELISA
  • FDA Topics
  • Gene Therapy
  • How we do
  • Immunology
  • Marin Bio Information
  • MLR
  • Molecular Biology
  • Patent Innovations
  • Publication
  • Targeted Protein Degradation

Our Services

  • Cell-based assays
  • Immunoassays
  • Flow cytometry
  • ELISA
  • Lot release assay
  • Drug stability
  • MLR
  • Protein
  • PCR/qPCR

Targeted Services

  • Gene Therapy
  • Antiviral Therapy
  • Immunotherapy
  • IDEA-to-IND

Sign Up to Stay in Touch!

[ctct form="783"]

Ready to Start Your Project?

Our Scientists can help you

Celebrating 27 Years of Our Clients' Trust

I consent to receive communications about my project from Marin Biologic Laboratories and understand their privacy policy.

Recent Posts

  • Photorealistic image showing ADC molecules binding to a cancer cell, illustrating the precision of cell-based assays in cancer treatment
    Revolutionizing Cancer Treatment: How Potency Assays Make ADCs More Effective
  • Potency Assay for Bispecific Antibody Constructs
  • Novel High Sensitivity Bispecific Antibody ELISA
  • Implementing cGMP Potency Assays in PROTAC Drug Development
  • Illustration of the ubiquitin-proteasome system tagging and degrading a protein, a process similar to PROTAC drug action
    Expanding the Toolbox of PROTAC Degraders with Covalent Ligands for Genetically Validated Targets
  • Expanding the Eligibility for AAV Gene Therapy with Monoclonal Antibodies
  • Capsid engineering of adeno-associated virus (AAV) vectors

Categories

  • All Blogs
  • Assay Development
  • Biochemistry
  • Cell Biology
  • Client Projects
  • Covid-19
  • ELISA
  • FDA Topics
  • Gene Therapy
  • How we do
  • Immunology
  • Marin Bio Information
  • MLR
  • Molecular Biology
  • Patent Innovations
  • Publication
  • Targeted Protein Degradation

links

  • About Us
  • Careers
  • FAQ
  • Glossary
  • Our Clients
  • Our Executive Team
  • Assay Requirements
  • GLP/GMP
  • Litigation
  • Non-GLP/GMP
  • Contact Us

services

  • ELISA
  • Flow Cytometry
  • Immunoassays
  • MLR
  • PCR-qPCR
  • Radiologic Assays – RadioImmunoAssays
  • The Art and Science of Cell Culture
  • Cell-Based Assays & Bioanalytical Services
  • Transfection
  • EXOSOMES
  • Protein
  • Molecular Biology and Microbiology
  • Stability Services
  • Lot Release Potency Assay/Test

contact

  • location

    378 Bel Marin Keys Blvd.
    Novato, CA 94949

  • phone

    415-883-8000

  • Email

    marinbio378@marinbio.com

Marin Biologic – FDA LogoFEI #3007996220
Marin Biologic Laboratories Custom Assay Experts

Marin Biologic Laboratories is an FDA registered Contract Laboratory that provides both Research and GLP/GMP services. We specialize in pre-clinical and clinical development, drug discovery and validation for biopharma companies with deep expertise in cell-based assays and immunoassays. Our unique approach to collaboration encourages scientists to talk to scientists to create better science.

© 2023 Marin Biologic Laboratories, Inc. — All Rights Reserved.

  • Terms of use
    • |
  • Privacy Notice

Speak to a Scientist

I consent to receive communications about my project from Marin Biologic Laboratories and understand their privacy policy.